Warburg Pincus Acquires Pregis from Olympus Partners

Warburg Pincus and ArchiMed Invest in Polyplus-transfection

April 29, 2020

Biotechnology

Warburg Pincus has made a major growth investment in Polyplus-transfection SA alongside existing majority shareholder ArchiMed, with both firms becoming equal shareholders while Polyplus management remains significant minority owners. The capital will be used to expand production capacity, accelerate product innovation, increase international expansion, and hire across technical, regulatory, and commercial functions to serve the gene and cell therapy market.

Warburg Pincus (Green Fin) Acquires Majority Stake in Parksons Packaging

April 26, 2021

Packaging

Green Fin Investments B.V., an affiliate of Warburg Pincus, acquired a majority stake in Parksons Packaging Limited, India’s largest independent folding carton manufacturer. Existing private equity investors Kedaara Capital AIF 1, Olza Holdings Limited and IIFL fully exited while the Kejriwal founder family sold a partial stake and will continue operating the business.

Warburg Pincus and Bessemer Lead ~$50M Series B Investment in Perfios

November 19, 2019

Software

Bangalore-based fintech software company Perfios raised approximately USD 50 million in a Series B round led by an affiliate of Warburg Pincus alongside Bessemer Venture Partners. The deal included primary capital and purchases of shares from early angel investors, with proceeds earmarked for technology/product innovation, international expansion (MENA and Southeast Asia) and potential acquisitions.

Warburg Pincus Invests $75M in Personetics

February 16, 2021

Payments & Fintech

Personetics, a provider of AI-driven personalization and customer engagement software for banks, raised $75 million in growth funding from Warburg Pincus to accelerate global expansion of its platform. The investment will support scaling distribution and product development as Personetics expands its footprint with banks across multiple markets.

Altaris Capital Partners Acquires Perrigo's Prescription Pharmaceuticals Business (Padagis)

March 1, 2021

Pharmaceuticals

Altaris Capital Partners has acquired Perrigo's prescription pharmaceuticals business for $1.55 billion and completed the carve-out, renaming the business Padagis. The business, a leader in generic prescription pharmaceuticals with more than 1,300 employees across six U.S. and Israeli locations and a portfolio of 200+ product families (800 SKUs), will be headquartered in the United States as a standalone company.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.